profit from every $100 of sales.
$0$100
Precision Optics
$5.23+4.60% today
+8.3% in 1 year
1-year low $3.901-year high $5.96
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
It has no yearly profit to compare the price with.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Precision Optics sold, what it kept, and what it did with the cash.
Sales went from $15.7 million in 2022 to $19.1 million in 2025, with -$5.78 million of profit last year.
SalesProfit
Precision Optics vs. similar companies
How it compares with the largest companies in its industry.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Precision Optics | No profit yet | ||
 ResMed | 22.1× · Fair price | ||
 West Pharmaceutical Services | 58.8× · Expensive | ||
 Hologic | 30.0× · Fair price | ||
 Baxter International | No profit yet |
AI analysis
An AI analyst reads Precision Optics's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 16 | 21 | 19 | 19 | |
| 5 | 8 | 6 | 3 | |
| -1 | -1 | -3 | -6 | |
| -1 | 0 | -3 | -5 | |
| -1 | -0 | -3 | -6 | |
| -0.18 | -0.03 | -0.49 | -0.85 | |
| 31.4% | 36.8% | 30.3% | 17.8% | |
| -8.6% | -3.0% | -14.3% | -29.1% | |
| -5.9% | -0.7% | -15.4% | -30.3% |
Balance sheet
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 17 | 20 | 17 | 20 |
| Cash | 1 | 3 | 0 | 2 |
| Total debt | 3 | 3 | 3 | 2 |
| Total liabilities | 8 | 8 | 7 | 8 |
| 9 | 12 | 10 | 12 | |
| 5 | 6 | 6 | 7 | |
| -5.1% | 0.4% | -15.9% | -30.7% | |
| -10.3% | -1.2% | -29.3% | -47.2% |
Cash flow
| In millions of USD | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -1 | -0 | -3 | -4 | |
| 0 | 0 | 0 | 0 | |
| -1 | -0 | -3 | -4 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 1 | 1 | 1 | 1 |
Valuation
- –
- –
- –
- 3.8×
- 3.0×
- –
- –
- -6.6%
- -10.1%
- 0.0%
Profitability
- 17.8%
- -29.1%
- -30.3%
- -26.5%
- -49.0%
- -14.8%
- -60.6%
- -30.2%
- -52.0%
- 4.1%
Growth
- +6.8%
- –
- −26.8%
- –
- +11.3%
Financial health
- –
- 0.47
- 19.3%
- -36.7×
- 1.05
- 0.62
- 1.07
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 7%of 952
Bottom 9%of 884
Bottom 37%of 886
Bottom 14%of 987
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| May 13, 2026 | -0.01 | – | – |
| Feb 17, 2026 | -0.23 | – | – |
| Sep 29, 2025 | -0.18 | – | – |
| May 15, 2025 | -0.30 | – | – |
| Feb 13, 2025 | -0.15 | – | – |
| Nov 14, 2024 | -0.21 | – | – |
| Sep 30, 2024 | -0.23 | – | – |
| May 15, 2024 | -0.05 | – | – |
News
Global Clinical Genomics Software Market Report 2026 | Capitalize on 14.8% CAGR Through 2030 as Google, Microsoft, NVIDIA and Illumina Scale AI, Cloud and Precision MedicineYahoo Finance · Nov 9, 2026Global Clinical Knowledge Graphs for Genomics Market Report 2026 | Capitalize on 20.7% CAGR as Microsoft, IBM, Illumina and Genomenon Scale AI, Cloud and Precision MedicineYahoo Finance · Oct 30, 2026Precision Drilling GAAP EPS of C$1.65 misses by C$0.45, revenue of C$531.65M beats by C$1.94MSeeking Alpha · Oct 28, 2026Catheter Precision to rebrand as Flyte Aviation, adopt VJET tickerSeeking Alpha · Oct 2, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
0/7Passes 0 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
12No pass
Benjamin Graham
21No pass
Philip Fisher
19No pass
Peter Lynch
36No pass
Joel Greenblatt
0No pass
Charlie Munger
15No pass
Terry Smith
12No pass
Questions about Precision Optics
Is Precision Optics a good stock to buy?
A business with weak numbers that is not profitable yet. 0 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Precision Optics AI analysis
What does Precision Optics do?
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It is in Medical - Instruments & Supplies.
Does Precision Optics pay a dividend?
No. Precision Optics does not pay a dividend at the moment.
Is Precision Optics stock halal?
Yes. Precision Optics passes our halal screen: its business is permitted and its debt is 4% of its market value, under the 30% limit. How we check
How has Precision Optics stock done over the past year?
Up 8.3% over the past twelve months, to $5.23. It traded between $3.90 and $5.96 and is 12.2% below its high.
Who are Precision Optics's competitors?
The largest listed companies in the same industry are ResMed, West Pharmaceutical Services, Hologic and Baxter International. The peers table on this page compares their profit, growth and price with Precision Optics's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.